Prurigo form of atopic dermatitis L20.

A particularly stubborn, often permanently itchy variant of atopic eczema with efflorescences as in Prurigo simplex subacuta. The disease occurs in 2 clinical variants:

• prurigo chlorescences with signs of atopic eczema
• Prurigoefflorescences without other signs of atopic eczema

This variant is described in childhood and as a late manifested form in adulthood.

Atopic eczema first manifested in childhood and adolescence: 5-10% of patients affected.

Atopic eczema first manifested in adulthood (after the 18th year of life): 3.2% of patients affected.

Mostly colorful clinical picture with sharply defined efflorescences of different "acuity" from fresh to "healed scarred".

Initial efflorescences (usually not detectable): "Urticarial", eminently itchy, 0.2-0.5 cm large, red papules. In most cases, however, there is no "precursor efflorescence" but only a piercing, tortuous, localized itching in normal appearing skin.

Residual efflorescence (typical clinical finding): 0.3-0.5 cm large, centrally scratched, moderately raised, red or reddish brown papules covered with a crust or fresh granulation tissue. In addition, depending on the duration of the disease symptoms, white scars of varying age, or reddened, selenium hyperpigmented scars in the size of the pre-existing prurigopapules.

Typical is a punctual, painfully piercing itching, which is answered with a typical scratching reaction (spooning); then the itching stops abruptly. It is not uncommon, however, to develop scratching automatisms that are difficult to interrupt.

Notice! It is not the "disturbing efflorescences" but the punctual, tormenting itching that leads to the doctor!

Clinical picture with evidence of the typical prurigoefflorescences (reddish-brown surface smooth or scratched papules)

Clarification of the family environment regarding atopic diseases

Clarification of atopic signs or additional atopic diseases (atopic rhinitis, atopic asthma, atopic food allergies, urticaria)

Confirmation of allergic diathesis by means of prick and RAST test.

S. Eczema, atopic.

It remains to be seen to what extent Dupilumab will be an effective therapeutic option in the treatment of this disease (Almustafa ZZ et al. 2019).

1. Almustafa ZZ et al(2019) Dupilumab in Treatment of Chronic Prurigo: A Case Series and Literature Review. Acta Derm Venereol doi: 10.2340/00015555-3243.
2. Hashimoto Tet al. (2015) Protective Role of STAT6 in Basophil-Dependent Prurigo-like Allergic Skin Inflammation. J Immunol 194: 4631-4640
3. Julián-Gónzalez RE et al (2012) Less common clinical manifestations of atopic dermatitis: prevalence by age. Pediatric Dermatol 29:580-583
4. Ozkaya E (2005) Adult-onset atopic dermatitis. J Am Acad Dermatol 52:579-582